Par-3 Partitioning Defective 3 Homolog (PARD3) Peptide
-
- Target See all PARD3 products
- PARD3 (Par-3 Partitioning Defective 3 Homolog (PARD3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EQQMKKQPPS EGPSNYDSYK KVQDPSYAPP KGPFRQDVPP SPSQVARLNR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PARD3 antibody,
Alternative Names: PARD3 control peptide, PARD3 antibody Blocking Peptide, Anti-PARD3 Blocking Peptide, Par-3 Partitioning Defective 3 Homolog Blocking Peptide, ASIP Blocking Peptide, Baz Blocking Peptide, Bazooka Blocking Peptide, FLJ21015 Blocking Peptide, PAR3 Blocking Peptide, PAR3alpha Blocking Peptide, PARD3A Blocking Peptide, SE2-5L16 Blocking Peptide, SE2-5LT1 Blocking Peptide, SE2-5T2 Blocking Peptide, PARD3, PARD-3, PARD 3, PARD-3 Blocking Peptide, PARD 3 Blocking Peptide - Purification
- Ascites, ammnonium sulphate purified
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PARD3 (Par-3 Partitioning Defective 3 Homolog (PARD3))
- Background
- PARD proteins, which were first identified in C. elegans, are essential for asymmetric cell division and polarized growth, whereas CDC42 mediates the establishment of cell polarity. The CDC42 GTPase, which is controlled by nucleotide exchange.
- Molecular Weight
- 151 kDa
-